Address: 30 Medical Center Blvd, Suite 303, Upland, PA 19013-3958
Practice Phone: (610) 872-8501
Research Staff Phone: (888) 219-3294
Hours: Monday–Friday: 8:30 AM–4:30 PM
We are currently enrolling patients in the following clinical trials:
• AstraZeneca BaxDuo-Arctic: A study for patients with chronic kidney disease and high blood pressure.
• AstraZeneca PACIFIC: A long-term study for patients with chronic kidney disease and high blood pressure.
• Boehringer Ingelheim/Duke: EASi-KIDNEY: A study for patients with chronic kidney disease at risk of progression.
• Maze Therapeutics: MZE829-201 (HORIZON): A study for patients with proteinuric chronic kidney disease and the APOL1 high risk genotype.
Vice President, Business Development
DJ Singh is the Vice President of Business Development for the Provider Group at Panoramic Health, where he leads strategic growth initiatives through new practice partnerships and acquisitions. In this role, DJ is responsible for expanding the organization’s national footprint while ensuring alignment with Panoramic Health’s physician-led mission and commitment to exceptional patient care.
DJ brings a strong background in healthcare M&A and corporate development, with experience spanning investment banking, private equity-backed growth, and multisite provider platforms. Prior to joining Panoramic Health, he led acquisition efforts at Mosaic Dental Collective, an Audax-backed dental services organization. He also held leadership roles in corporate development at AGS Health, DaVita Dialysis, and Vox Media, where he supported both inorganic and organic growth strategies.
Board Member
Alec Cunningham is a proven public– and private-company CEO who has delivered excellent operating results and has extensive expertise in both the policy and operations of government-sponsored health care programs and provider organizations. Previously, Cunningham served as Executive Vice President of CVS Health where he focused on the integration of health services and provider assets to optimize the value of CVS Health’s offerings in the marketplace. His prior roles at CVS Health included Chief Operating Officer of Aetna and EVP of Aetna’s Government Business.
Before joining CVS Health, Cunningham was the President and Chief Executive Officer for ConcertoHealth (previously Fidelis SeniorCare). Prior to that, he spent nearly a decade in senior leadership roles with WellCare Health Plans, including as the Chief Executive Officer. During his tenure as CEO, Cunningham led a strategic and operational transformation of the company that resulted in a near doubling of revenue, earnings per share, and share price over a four-year period. Earlier in his career, Cunningham successfully led the national business development efforts for the State-Sponsored Programs division of WellPoint (subsequently Anthem and now Elevance Health) to expand beyond California into multiple new markets and products nationwide.